PRESS RELEASE published on 05/06/2025 at 14:31, 1 year 6 months ago Monogram Technologies to Host First Quarter 2025 Results Conference Call on Wednesday, May 14, 2025 at 4:30 p.m. Eastern Time Monogram Technologies Inc. to host conference call webcast on May 14, 2025, discussing Q1 financial results, FDA 510(k) Clearance for mBôs TKA System, and upcoming clinical trials in India Financial Results Conference Call Clinical Trials FDA 510(k) Clearance Monogram Technologies Inc.
PRESS RELEASE published on 05/06/2025 at 14:30, 1 year 6 months ago Gladstone Commercial Corporation Earnings Call and Webcast Information Gladstone Commercial Corporation announces First Quarter Ended March 31, 2025 Earnings Call & Webcast on May 8, 2025, at 8:30 a.m. ET. Details for participation provided Conference Call Gladstone Commercial Corporation REIT Webcast Earnings
PRESS RELEASE published on 05/06/2025 at 14:30, 1 year 6 months ago Trans Canada Gold Corp. Ships 3,919 Barrels for the Month of April 2025, From its Lloydminster Multilateral Heavy Oil Well and Prepares for the Summer Mulitlateral Drilling Program Trans Canada Gold Corp announces completion of another month of steady oil production for April 2025 and plans to commence drilling a multi-lateral well targeting Sparky formation in summer 2025 Drilling Oil Production Multilateral Well Sparky Formation Trans Canada Gold Corp
PRESS RELEASE published on 05/06/2025 at 14:30, 1 year 6 months ago GPOPlus+ Engages Strategic Innovations to Launch Next-Gen IR Program for Shareholder Engagement GPO Plus, Inc. launches new investor relations initiative with Strategic Innovations First to enhance transparency and shareholder relationships, reflecting scalable growth and commitment Shareholders Investor Relations Transparency GPO Plus Inc. Strategic Innovations First
PRESS RELEASE published on 05/06/2025 at 14:30, 1 year 6 months ago Loar Holdings Inc. Announces Date and Time for First Quarter 2025 Earnings Conference Call Loar Holdings Inc. (NYSE: LOAR) to report Q1 2025 earnings on May 13, 2025. Conference call details provided. Company overview and contact information included Conference Call Aerospace Loar Holdings Inc. Defense Components Q1 2025 Earnings
PRESS RELEASE published on 05/06/2025 at 14:21, 1 year 6 months ago Original-Research: PSI SE (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research increases PSI SE's price target to €40 with a Buy recommendation after Q1/25 results. Order intake up 66.3% in Q1 due to E.ON partnership and post-cyberattack effects First Berlin Equity Research Buy Recommendation Price Target Increase PSI SE Q1/25 Results
PRESS RELEASE published on 05/06/2025 at 14:03, 1 year 6 months ago Original-Research: Zalando SE (von Quirin Privatbank Kapitalmarktgeschäft): Buy Zalando SE obtains Buy recommendation from Quirin Privatbank Kapitalmarktgeschäft for Q1 2025 performance, confirming full-year outlook. Read the research for more details Buy Recommendation Zalando SE Full-year Outlook Quirin Privatbank Q1 2025
PRESS RELEASE published on 05/06/2025 at 14:01, 1 year 6 months ago Tharimmune Presents Positive Clinical Data Highlighting TH104 Metabolic Profile and Advances Program for Prophylaxis Against Ultrapotent Opioid Exposure Following FDA Feedback Tharimmune, Inc. presents promising pharmacokinetic and metabolism data of TH104, a buccal film of nalmefene, for prophylaxis against opioid exposure. Study results showcased at Digestive Disease Week 2025 Tharimmune Inc. TH104 Buccal Film Pharmacokinetic Study Opioid Prophylaxis
PRESS RELEASE published on 05/06/2025 at 14:00, 1 year 6 months ago Galimedix Therapeutics completes single ascending dose part of Phase 1 study with oral small molecule, GAL-101, an amyloid beta aggregation modulator Galimedix Therapeutics completes single ascending dose of Phase 1 study with oral small molecule GAL-101 targeting amyloid beta aggregation modulator, supporting oral administration route. Next study arms and indications revealed Galimedix Therapeutics GAL-101 Oral Administration Phase 1 Study Amyloid Beta
PRESS RELEASE published on 05/06/2025 at 14:00, 1 year 6 months ago Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization New analysis shows Xifaxan efficacy in reducing OHE rehospitalizations regardless of prior treatment. Data presented at DDW 2025 XIFAXAN Bausch Health Gastroenterology OHE Rehospitalizations
Published on 11/11/2026 at 19:31, 3 hours 2 minutes ago Lion Copper Corp. Completes S-K 1300 Technical Report Summary for Bear Copper Deposit
Published on 11/11/2026 at 16:30, 6 hours 3 minutes ago ShelfieTech Announces Expansion Agreement for Its Next-Generation AI Retail Intelligence Platform
Published on 11/11/2026 at 14:00, 8 hours 33 minutes ago PPX Mining Reports Callanquitas Operating Results for the First Nine Months of 2026
Published on 11/11/2026 at 14:00, 8 hours 33 minutes ago NuRAN Wireless Board Approves Growth Strategy to Scale Recurring Revenue from 5,000+ Contracted Towers
Published on 11/11/2026 at 19:29, 3 hours 4 minutes ago EQS-Adhoc: Allianz SE: Allianz delivers record nine-month result of 14.1 billion euros and raises 2026 outlook
Published on 11/11/2026 at 18:41, 3 hours 51 minutes ago AUSTRIACARD HOLDINGS AG: 9M 2026 Financial Results
Published on 11/10/2026 at 17:31, 1 day 5 hours ago CNP Assurances SA announces the success of the issuance of a €500 million Tier 2 subordinated bond.
Published on 11/10/2026 at 14:00, 1 day 8 hours ago Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 1 day 11 hours ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 1 day 15 hours ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 2 days 4 hours ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond